| Ytd | -4.19% | |
| 1y | 10.97% |
| Open | 321.11 | Prev Close | 322.03 | Low | 319.04 | High | 326.57 | Mkt Cap | 61.75B |
| Vol | 1.39M | Avg Vol | 1.46M | EPS | 13.53 | P/E | 23.92 | Forward P/E | 16.36 |
| Beta | 0.57 | Short Ratio | 3.03 | Inst. Own | 99.64% | Dividend | 2.40 | Div Yield | 0.75 |
| Ex Div Date | 08-14 | Earning | 11-04 | 50-d Avg | 306.83 | 200-d Avg | 322.73 | 1yr Est | 369.31 |
Connor Clark and Lunn Investment Management Ltd. acquired a new stake in shares of Cencora, Inc. (NY
Walmart agreed to pay $50 million to settle a DOJ lawsuit alleging its pharmacies unlawfully filled
Invesco Discovery Mid Cap Growth Fund had a positive return and outperformed its benchmark in the se
Advisors Capital Management LLC purchased a new stake in shares of Cencora, Inc. (NYSE: COR) in the
Cencora (NYSE:COR) has outperformed the market over the past 10 years by 6.61% on an annualized basi
RBC Capital analyst Ryan Halsted initiates coverage on Cencora (NYSE:COR) with a Sector Perform r
These healthcare companies can actually benefit from inflation.
Cencora (NYSE:COR) has outperformed the market over the past 10 years by 6.29% on an annualized basi
Beginning July 1, 2026, certain Walgreens volume that was being serviced by Cencora, Inc. (the "
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the
Shares of Cencora, Inc. (NYSE: COR - Get Free Report) have been assigned a consensus recommendation
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investi
Wells Fargo analyst Stephen Baxter maintains Cencora (NYSE:COR) with a Overweight and raises the
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investi
Morgan Stanley analyst Erin Wright maintains Cencora (NYSE:COR) with a Overweight and raises the
JP Morgan analyst Lisa Gill maintains Cencora (NYSE:COR) with a Overweight and raises the price t
Weak U.S. jobs data boosts hopes for a Fed pause, sending AI chip stocks and other high-beta tech na
Evercore ISI Group analyst John Belton maintains Cencora (NYSE:COR) with a Outperform and raises
Allspring Growth Fund outperformed the Russell 3000 Growth Index during the quarter. Sandisk Corp. i
Cencora NYSE: COR reported fiscal 2026 third-quarter results marked by double-digit adjusted operati
Cencora, Inc. (COR) Q3 2026 Earnings Call Transcript
Cencora Inc. (NYSE:COR) on Wednesday reported third-quarter adjusted earnings of $4.48 per share, be
Cencora beats third-quarter earnings and revenue estimates, raised fiscal 2026 EPS guidance and main
Cencora's fiscal Q3 EPS beats estimates as broad segment growth lifts profit, prompting a higher 202
Although the revenue and EPS for Cencora (COR) give a sense of how its business performed in the qua
Cencora (COR) came out with quarterly earnings of $4.48 per share, beating the Zacks Consensus Estim
U.S. drug distributor Cencora raised its annual adjusted profit forecast on Wednesday after quarterl
Cencora (NYSE:COR) raises FY2026 Adj EPS guidance from $17.70-$17.90 to $17.75-$17.95 vs $17.79 anal
Cencora (NYSE:COR) reported quarterly earnings of $4.48 per share which beat the analyst consensus e
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) reported that in its fiscal year 2026
McKesson, Cencora, Solventum and PacBio head into earnings with resilient demand offset by tariffs,
The U.S. Federal Trade Commission is taking a closer look at a proposed $3.5 billion acquisition t
COR's Q3 results could reflect specialty pharma strength, oncology expansion and margin gains, even
Company Advances Strategic Pharmacy Relationships, Expands Commercial Pipeline and Positions for Con
B of A Securities analyst Michael Funk maintains Cencora (NYSE:COR) with a Neutral and raises the
Barclays analyst Glen Santangelo maintains Cencora (NYSE:COR) with a Overweight and lowers the pr
The battle between Amazon.com and Walmart has produced a new leader for the Fortune 500 list for 202
CONSHOHOCKEN, Pa. [June 2, 2026] — Cencora today announced an agreement with Kite , a Gilead Company
Cencora, Inc. (NYSE:COR) today announced Eva C. Boratto has been appointed Executive Vice President
Cencora, Inc. (NYSE:COR) today updated its fiscal year 2026 financial guidance as a result of recent
Wells Fargo analyst Stephen Baxter maintains Cencora (NYSE:COR) with a Overweight and lowers the
Citigroup analyst Daniel Grosslight maintains Cencora (NYSE:COR) with a Buy and lowers the price
Evercore ISI Group analyst John Belton maintains Cencora (NYSE:COR) with a Outperform and lowers
Baird analyst David Rodgers maintains Cencora (NYSE:COR) with a Outperform and lowers the price t
Cencora stock falls after Q2 earnings miss and lower sales guidance, despite raising EPS outlook and
U.S. stocks hit records as Trump's Iran memo sinks oil 6%, AMD soars 17% on data-center beat.
Cencora (NYSE:COR) raises FY2026 Adj EPS guidance from $17.45-$17.60 to $17.65-$17.90 vs $17.60 anal
Cencora (NYSE:COR) reported quarterly earnings of $4.75 per share which missed the analyst consensus